Skip to main content
SpringerLink
Log in

Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Postprandial glucose has been reported to be the best predictor of neonatal macrosomia. Therefore, self-blood glucose monitoring (SBGM) protocols for diabetic pregnant women stress the importance of measuring blood glucose after meals. However, there is controversy in the literature. Traditionally, glucose monitoring has been prescribed at 2 hours after eating to coincide with the times a patient is at increased risk of hypoglycemia. Human regular insulin peaks at 2 to 3 hours after injection; thus, checking blood glucose at the 2-hour point is a relic of strategies to prevent hypoglycemia. In pregnancy, the emphasis has been on measuring during times when blood glucose levels are highest. One hour after the start of the meal has been shown to be the time of peak postprandial response in 90% of pregnant woman. Because glucose excursions may reach their maximum at varying times, based on the size and number of meals ingested, SBGM alone may not capture the full extent of total daily postprandial hyperglycemia. Because intermittent blood glucose monitoring underestimates the number of hyperglycemic events, a more accurate determination of postprandial glucose levels is necessary to decrease the risk of macrosomia in gestational diabetes mellitus. Continuous glucose monitoring may facilitate the detection of all postprandial peaks, including those due to unscheduled meals, and may provide an opportunity for better intervention by providing the complete glucose profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jovanovic L: Medical Management of Pregnancy Complicated by Diabetes. Alexandria: American Diabetes Association; 2000. This is a health care professional’s guide to the management of pregnancies complicated by diabetes.

    Google Scholar 

  2. Engelgau M, German R, Herman W, et al.: The epidemiology of diabetes and pregnancy in the US, 1988. Diabetes Care 1995, 18:1029–1033.

    Article  PubMed  CAS  Google Scholar 

  3. McCance DR, Pettitt DJ, Hanson RL, et al.: Birth weight and non-insulin-dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ 1994, 398:942–945.

    Google Scholar 

  4. Langer O, Mazze R: The relationship between large-for-gestational- age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol 1988, 159:1478–1483.

    PubMed  CAS  Google Scholar 

  5. Persson B, Hanson U: Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998, 21(suppl 2):B79-B84.

    PubMed  Google Scholar 

  6. Jovanovic L, Crues J, Durak E, Peterson CM: Magnetic resonance imaging in pregnancies complicated by diabetes predicts infant birthweight ratio and neonatal morbidity. Am J Perinatol 1993, 10:432–437.

    Google Scholar 

  7. Jovanovic L, Bevier W, Peterson CM: The Santa Barbara County Health Care Services Program: birth weight change concomitant with screening for and treatment of glucoseintolerance of pregnancy: a potential cost-effective intervention. Am J Perinatol 1997, 14:221–228.

    Google Scholar 

  8. Rosenn BM, Miodovnik M: Glycemic control in the diabetic pregnancy: is tighter always better? J Matern Fetal Med 2000, 9:29–34.

    Article  PubMed  CAS  Google Scholar 

  9. Hod M, Rabinerson D, Peled Y: Gestational diabetes mellitus: is it a clinical entity? Diabetes Rev 1995, 3:603–613.

    Google Scholar 

  10. Ogata ES: Perinatal morbidity in offspring of diabetic mothers. Diabetes Rev 1995, 3:652–657.

    Google Scholar 

  11. Langer O: Is normoglycemia the correct threshold to prevent complications in the pregnant diabetic patient? Diabetes Rev 1995, 4:2–10.

    Google Scholar 

  12. Jovanovic L, Reed GF, Metzger BE, et al.: Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study: The National Institute of Child Health and Human Development—Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991, 164:103–111.

    Google Scholar 

  13. Combs CA, Gunderson E, Kitzmiller JL, et al.: Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992, 15:1251–1257.

    Article  PubMed  CAS  Google Scholar 

  14. deVeciana M, Major CA, Morgan MA: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995, 333:1237–1241.

    Article  PubMed  Google Scholar 

  15. Moses RG, Lucas EM, Knights S: Gestational diabetes mellitus: at what time should the postprandial glucose level be monitored? Aust N Z J Obstet Gynecol 1999, 39:457–460.

    CAS  Google Scholar 

  16. Jovanovic L, Ilic S, Pettitt DJ, et al.: Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999, 22:1422–1427. Optimal treatment of gestational diabetic women is to target postprandial glucose levels to be less than 120 mg/dL. Use of the insulin analogue lispro facilitates postprandial glucose control.

    Article  PubMed  CAS  Google Scholar 

  17. Polansky KS, Given BD, Hirsch LJ, et al.: Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1988, 318:1231–1239.

    Article  Google Scholar 

  18. Aussedat B, Dupire-Angel M, Gifford R, et al.: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000, 278:E716-E728.

    PubMed  CAS  Google Scholar 

  19. Mastrototaro J. The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 1999, 12 Suppl 3:751–8.

    Google Scholar 

  20. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999, 46:183–190. This is the first report to show that the use of continuous glucose monitoring improves glucose control.

    Article  PubMed  CAS  Google Scholar 

  21. Haak T: New developments in the treatment of type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 1999, 107(suppl 3):S108-S113.

    Article  PubMed  CAS  Google Scholar 

  22. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999, 277:E561-E571.

    PubMed  CAS  Google Scholar 

  23. Gerritsen M, Jansen JA, Lutterman JA: Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med 1999, 54:167–179.

    Article  PubMed  CAS  Google Scholar 

  24. Tamada JA, Garg S, Jovanovic L, et al.: Noninvasive glucose monitoring comprehensive clinical results. JAMA 1999, 282:1839–1844. This article demonstrates the use of real-time glucose levels in the management of diabetes using reverse iantophoresis (GlucoWatch; Cygnus, Redwood City, CA).

    Article  PubMed  CAS  Google Scholar 

  25. Jovanovic L, Peterson CM: Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med 1983, 75:607–6l2.

    Article  PubMed  CAS  Google Scholar 

  26. Jovanovic L, Druzin M, Peterson CM: Effect of euglycemia on the outcome of pregnancy in insulin dependent diabetic women as compared to normal controls. Am J Med 1981, 71:921–927.

    Article  PubMed  CAS  Google Scholar 

  27. Jovanovic L, Peterson CM, Saxena BB, et al.: Feasibility of maintaining euglycemia in insulin-dependent diabetic women. Am J Med 1980, 68:l05–112.

    Article  Google Scholar 

  28. Durak EP, Jovanovic L, Peterson, CM: Comparative evaluation of five aerobic machines and their effect on uterine activity during pregnancy. Am J Obstet Gynecol 1990, 162:754–756.

    PubMed  CAS  Google Scholar 

  29. Jovanovic L, Meisel B, Bevier W, Peterson CM: The Rubenesque pregnancy: a progression towards higher blood pressure correlates with a measure of endogenous and exogenous insulin levels. Am J Perinatol 1997, 14:181–186.

    Article  Google Scholar 

  30. Jovanovic L: American Diabetes Association’s Fourth International Workshop-Conference on Gestational Diabetes Mellitus: summary and discussion: therapeutic interventions. Diabetes Care 1998, 21(suppl 2):B131-B137.

    PubMed  Google Scholar 

  31. Jovanovic L: The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technol Ther 2000, 2(suppl 1):S67-S71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sansum Medical Research Institute, 2219 Bath Street, 93105, Santa Barbara, CA, USA

    Lois Jovanovic MD

Authors
  1. Lois Jovanovic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jovanovic, L. Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus. Curr Diab Rep 1, 82–85 (2001). https://doi.org/10.1007/s11892-001-0015-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-001-0015-9

Keywords

Search

Navigation